<--- Back to Details
First PageDocument Content
Depression / Abnormal psychology / Psychiatry / Neurochemistry / Antidepressant / Major depressive disorder / Suicidal ideation / Management of depression / Antidepressants and suicide risk
Depression
Abnormal psychology
Psychiatry
Neurochemistry
Antidepressant
Major depressive disorder
Suicidal ideation
Management of depression
Antidepressants and suicide risk

Medication Guide Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 92,92 KB

Share Document on Facebook

Similar Documents

Medication Guide   Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

Medication Guide Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions

DocID: 1rlMD - View Document

24. März 2016 FINANCIAL SERVICES OVERVIEW  Complete transparency of

24. März 2016 FINANCIAL SERVICES OVERVIEW Complete transparency of

DocID: 1rk8W - View Document

U.S. SOCCER NATIONAL TEAMS CONCUSSION EVALUATION & MANAGEMENT PROTOCOLS The Return To Play (RTP) decision-making process after concussion is one of the most complicated in sports medicine. Despite ongoing research, the c

U.S. SOCCER NATIONAL TEAMS CONCUSSION EVALUATION & MANAGEMENT PROTOCOLS The Return To Play (RTP) decision-making process after concussion is one of the most complicated in sports medicine. Despite ongoing research, the c

DocID: 1qHSN - View Document

A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major Depressive Disorders Stephen C. Suffin, M.D. W. Hamlin Emory, M.D. Nicholas Gutierrez, M.D.

A QEEG Database Method for Predicting Pharmacotherapeutic Outcome in Refractory Major Depressive Disorders Stephen C. Suffin, M.D. W. Hamlin Emory, M.D. Nicholas Gutierrez, M.D.

DocID: 1qAQC - View Document

Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits? Benefits of SSRIs  Joel M. Kauffman, Ph.D.

Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits? Benefits of SSRIs Joel M. Kauffman, Ph.D.

DocID: 1pY1S - View Document